Patent Assignment

Assignment of Assignor's Interest

View PDF Order Certified Copy

Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom

Pharmaceutical formulations: salts of 8-[1-3,5-Bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

NK1 Antagonists

Hydrochloride salts of 8-[1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor

Hydrochloride Salts of 8-[{1-(3,5-Bis-(Trifluoromethyl)Phenyl)-Ethoxy)-Methyl]-8-Phenyl-1,7-Diaza-Spiro[4.5]Decan-2-One and Preparation Process Therefor

Process and intermediates for the synthesis of 8-[[1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy]-methyl]-8phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds

Intravenous Formulations of Neurokinin-1 Antagonist

Process and Intermediates for the Syntheses of 8-[{1-(3,5-Bis-(Trifluoromethyl)Phenyl)-Ethoxy}-Methyl]-8-Phenyl-1,7-Diaza-Spiro[4.5]Decan-2-One Compounds

Nk 1 Antagonists

Pharmaceutical Formulations: Salts of 8-[{1-(3,5-Bis-(Trifluoromethyl)Phenyl)-Ethoxy}-Methyl]-8-Phenyl-1,7-Diaza-Spiro[4.5]Decan-2-One and Treatment Methods Using the Same